About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
LUNG
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Pulmonx GAAP EPS of -$0.36 beats by $0.06, revenue of $19.27M beats by $1.03M
- Pulmonx announces retirement of president and CEO Glen French
- Pulmonx GAAP EPS of -$0.39 beats by $0.04, revenue of $17.7M beats by $1.03M
- Pulmonx announces departure of finance chief Derrick Sung
- BofA Securities: Which small cap non-earner stocks to avoid
- Pulmonx GAAP EPS of -$0.43 beats by $0.02, revenue of $17.2M beats by $1.34M
- Pulmonx GAAP EPS of -$0.42 beats by $0.02, revenue of $14.5M beats by $1.01M
- Pulmonx GAAP EPS of -$0.38 beats by $0.04, revenue of $15.43M beats by $1.45M
- Point72 Asset Management shows 5.3% stake in Pulmonx
- BofA downgrades Pulmonx to Underperform on limited upside potential
- Pulmonx surges 10% on Japanese approval of Zephyr valve for lung disorders
- Pulmonx stock crashes 53% as FY22 outlook slashed, Q3 revenue miss estimates
- Pulmonx GAAP EPS of -$0.38 beats by $0.01, revenue of $13.5M misses by $1.43M
- Pulmonx GAAP EPS of -$0.40 in-line, revenue of $14M beats by $0.23M
- Pulmonx GAAP EPS of -$0.43 misses by $0.06, revenue of $10.8M beats by $1.54M
- Pulmonx stock falls as FY22 revenue outlook seen below estimates
- Pulmonx GAAP EPS of -$0.35 beats by $0.01, revenue of $13.7M misses by $0.54M
- Pulmonx upgraded to overweight at Piper on attractive valuation; sees 33% upside
- Pulmonx EPS beats by $0.09, beats on revenue
- Pulmonx EPS beats by $0.04, beats on revenue